0001209191-23-044528.txt : 20230803
0001209191-23-044528.hdr.sgml : 20230803
20230803180016
ACCESSION NUMBER: 0001209191-23-044528
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20230731
FILED AS OF DATE: 20230803
DATE AS OF CHANGE: 20230803
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Thomas Dolca
CENTRAL INDEX KEY: 0001768239
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38582
FILM NUMBER: 231141490
MAIL ADDRESS:
STREET 1: C/O PRINCIPIA BIOPHARMA INC.
STREET 2: 220 E. GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allakos Inc.
CENTRAL INDEX KEY: 0001564824
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 454798831
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 825 INDUSTRIAL ROAD
STREET 2: SUITE 500
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
BUSINESS PHONE: 650-597-5002
MAIL ADDRESS:
STREET 1: 825 INDUSTRIAL ROAD
STREET 2: SUITE 500
CITY: SAN CARLOS
STATE: CA
ZIP: 94070
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2023-07-31
1
0001564824
Allakos Inc.
ALLK
0001768239
Thomas Dolca
C/O ALLAKOS INC.
825 INDUSTRIAL ROAD, SUITE 500
SAN CARLOS
CA
94070
1
0
0
0
/s/ H. Baird Radford, III, by power of attorney
2023-08-03
EX-24
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
The undersigned, as a Section 16 reporting person of Allakos Inc. (the
"Company"), hereby constitutes and appoints the Company's Chief Executive
Officer, President, Chief Financial Officer, Chief Accountant, General Counsel,
Vice President Legal, and each of them, as the undersigned's true and lawful
attorney-in-fact to:
1. prepare, execute in the undersigned's name and on the undersigned's behalf,
and submit to the Securities and Exchange Commission (the "SEC") a Form ID,
including amendments thereto, and any other documents necessary or appropriate
to obtain EDGAR codes and passwords enabling the undersigned to make electronic
filings with the SEC of reports required by Section 16(a) of the Securities
Exchange Act of 1934 or any rule or regulation of the SEC;
2. complete and execute Forms 3, 4 and 5 and other forms and all amendments
thereto as such attorney-in-fact shall in his discretion determine to be
required or advisable pursuant to Section 16 of the Securities Exchange Act of
1934 (as amended) and the rules and regulations promulgated thereunder, or any
successor laws and regulations, as a consequence of the undersigned's ownership,
acquisition or disposition of securities of the Company; and
3. do all acts necessary in order to file such forms with the SEC, any
securities exchange or national association, the Company and such other person
or agency as the attorneys-in-fact shall deem appropriate. The undersigned
hereby ratifies and confirms all that said attorneys-in-fact and agents shall do
or cause to be done by virtue hereof.
The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in
such capacity at the request of the undersigned, are not assuming, nor is the
Company assuming, any of the undersigned's responsibilities to comply with
Section 16 of the Securities Exchange Act of 1934 (as amended).
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
Company and the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 22 day of July, 2023.
Signature: /s/ Dolca Thomas
Print Name: Dolca Thomas